Low and variable efficiency is a major problem in targeted gene alteration, which is used as a primary tool in gene therapy and animal model studies. We tested several types of constructs alone, or in combination with other factors, to introduce a point mutation into the aB-crystallin gene in onecelled mouse embryos. We found that co-injection of ssDNA along with antibodies against Ku70/86, or supplementing the system with hRad51/hRad54, increases efficiency of targeted mutagenesis. These findings suggest that proteins in the homologous recombination DNA repair pathway contribute, and that proteins involved in the alternative nonhomologous end-joining pathway inhibit, ssDNA-mediated targeted mutagenesis. This is the first successful demonstration of targeted mutation in early mouse embryos. This novel methodology of supplying protein factors to stimulate gene modification in the nucleus has not been previously reported.
Site-specific gene alteration by precise gene repair mechanisms is the ultimate goal in somatic gene therapy and in generating animal models of human genetic diseases via knockout/knock-in technology. Targeted genome alteration in the one-celled embryo would be ideal, however, attempts to accomplish this have not yet been successful. 1 Currently, the production of knockout and knock-in animals utilizes gene recombination techniques in mouse embryonic stem cells, followed by transferring selected stems cells into blastocysts to create a chimeric animal. Several laboratories have studied gene correction in mouse embryonic stems cells. 2, 3 Even if the mutation efficiency can be increased sufficiently, the selection and screening of embryonic stem cell clones and the microinjection of selected stem cells into blastocysts are still required. Gene alteration directly in one-celled embryos will eliminate many costly and timeconsuming steps in this process. However, early mouse embryos have never been demonstrated to potentiate targeted gene alteration. This is a unique, rapidly developing and changing system distant from any other described for genomic DNA alteration. There is limited data for mouse ova and early embryos suggesting a rapid change in double-strand DNA (dsDNA) break repair pathways, 4 which could greatly affect gene correction efficiency.
In other model systems, a variety of synthetic oligonucleotide constructs has been successfully used: triple helix-forming oligonucleotides (TFO), 5, 6 chimeric RNA/DNA constructs, [7] [8] [9] [10] peptide nucleic acids, 11 short DNA fragments, 12 and single-strand DNA (ssDNA). [13] [14] [15] However, the necessity of having a specific sequence of targeted DNA, and restrictions for triplex formation under physiological conditions, 16 impose serious limitations on the universality of TFOs as mutation mediators. Moreover, the previously reported efficiency of gene alteration mediated by chimeric RNA/DNA constructs cannot be reproduced by many experienced laboratories. [17] [18] [19] Efficiencies of up to 1% DNA alteration have been reported for simple ssDNA constructs, which make them similar to, or even better than, chimeric RNA/DNA. 13, 14 The precise mechanism of targeted gene alteration mediated by ssDNA or chimeric RNA/DNA constructs is not completely understood. Studies present controversial data that suggest the importance of major proteins from several DNA repair pathways. Earlier reports have implicated the MSH2 protein (a member of the mismatch repair pathway) in RNA/DNA construct-directed mutagenesis. 20 Further research suggests an increased alteration efficiency by Rad51 and Rad54 (the major factors in homologous recombination (HR)). 15, 21 An association between targeted mutation and other pathways that are distinct from HR 22 has also been described. The role of ERCC1/XPF and XPG (factors in the nucleotide excision repair pathway) 23 has been shown in another study. Additional studies clarifying the mechanisms and enzymes involved in this type of targeted DNA mutation are essential.
Here we introduced a point mutation into genomic DNA at the earliest stages of mouse embryo development. We examined the competence of chimeric RNA/ DNA, morpholino and ssDNA constructs to introduce this point mutation, and the effect of key factors in dsDNA break repair pathways on the efficiency of targeted gene alteration. Microinjection of one-celled mouse embryos allowed delivery of controlled amounts of the construct alone, or in combination with other factors, directly into pronuclei, with minimal embryo-toembryo variation. Our research identifies some proteins, which increase efficiency of targeted mutagenesis in onecell mouse embryos, and further support the involvement of the HR pathway.
We have used the aB-crystallin gene (Cryab, Crya2, Hspb5) as a model target for generating point mutations in the genome. Substitution of guanosine for adenosine converts tryptophan at codon 9 of this gene into a stop codon. If the targeted alteration is successful, a BamH I endonuclease site will be lost and concomitantly a Hinf I site will be created ( Figure 1a ).
Based on nested PCR amplification, we developed a sensitive method of genomic DNA amplification that is capable of determining a single copy DNA (Supplementary information). Sequential amplification with two different sets of primers in the nested PCR substantially reduced the impact of nonspecific DNA. We also used high fidelity Tli DNA polymerase, with 3 0 -5 0 proofreading activity, to minimize sequence amplification errors. The final product of the nested PCR reaction was 111 bp. Successful targeting events were judged in a restriction fragment length polymorphism (RFLP) assay by simultaneous loss of the BamH I site (53 and 58 bp digestion products for wild-type DNA and 111 bp for mutated DNA) and appearance of a Hinf I site (5 and 106 bp digestion products for wild type and 5, 48 and 58 bp for mutated DNA; Figure 1a ). To increase the reliability of our assays, we always conducted RFLP analyses with both nucleases.
The chemical nature of the mutagenic construct in this type of targeted mutagenesis experiment is of paramount importance. Early reports claimed mutation rates up to 30% with chimeric RNA/DNA constructs. [7] [8] [9] [10] However, when we performed several experiments microinjecting a chimeric RNA/DNA construct into mouse embryonic pronuclei, we were unable to detect any mutation events (data not shown). Morpholinos, having the advantages of minimal embryonic toxicity and complete resistance to nucleases, were also tested as a mediator of targeted mutagenesis in our experiments. A morpholino was synthesized to target the nontranscribed DNA strand. Based on the double-RFLP analysis, the injected morpholino construct failed to introduce the desired targeted mutation into embryonic DNA (data not shown). From a practical standpoint, the simplicity of ssDNA would make it ideal for targeted mutagenesis, and indeed, high efficiency rates for ssDNA-mediated mutagenesis have been reported. 13, 14 In our experiments 66 nucleotide-long oligonucleotides targeting either the transcribed or the nontranscribed strand, and a 74 nucleotide oligonucleotide targeting the nontranscribed strand were used (Figure 1b) . However, all ssDNA constructs were unable to introduce the desired mutation in codon 9 of the aBcrystallin gene. The number of embryos surviving Targeted mutagenesis in early mouse embryos V Morozov and EF Wawrousek microinjection varied from 35 to 120 for different constructs. Low alteration efficiency and the limited number of surviving embryos in these experiments were statistically insufficient to determine a true alteration efficiency, which is probably slightly larger than the reported 0%.
Since low and variable efficiency is a major problem for gene alteration, we hypothesized that supplementation with stimulating factors, or suppression of inhibitory factors in competing pathways, would increase modification rates. Involvement of the dsDNA break repair mechanism in oligonucleotide-mediated mutagenesis has been suggested. 15, 21 dsDNA break repair employs two major competing pathways in mammalian cells: HR, and the more predominant nonhomologous end joining (NHEJ). 24 A 74 nucleotide ssDNA construct with three phosphorothioate bonds at each end, and targeting the nontranscribed DNA strand, was used (Figure 1b) . We co-injected this ssDNA construct along with rabbit polyclonal antibodies directed against Rad51 or Ku70/86, which are key DNA-binding proteins in the HR and NHEJ pathways, respectively. Co-injection of the ssDNA with antibodies against Rad51 did not increase the modification efficiency (data not shown). When Ku70/86 proteins were inhibited by co-injection of polyclonal antibodies along with the 74 nucleotide-long ssDNA, mutation events were detected by the BamH I RFLP assay (Figure 2a) . When the RFLP analysis was repeated with Hinf I (Figure 2b ), an accumulation of diffuse bands in the area of 48-58 bp, compared to the undigested nested PCR product (Figure 2b, lanes 2 and 5) , confirmed the single base replacement targeting event. Sybr Gold for band visualization in our gel system failed to clearly resolve small DNA fragments, therefore, comigration of Hinf I digestion fragments with nonspecific PCR products resulted in a smear below 50 bp. To determine the number of successfully targeted DNA copies within an individual embryo, we measured the intensities of the bands corresponding to mutated and wild-type DNA and calculated the percent mutation (Figure 2c ). For Hinf I digestion we calculated the band intensity as the difference between uncleaved PCR products and Hinf I digestion products in the 48-58 bp region. Quantitation using this method on both BamH I and Hinf I RFLP data revealed that approximately 20% of DNA copies within each embryo were the mutated form. Development of these two embryos was arrested at the one-cell stage. However, with the presence of a psuedodiploid and a haploid polar body within the zona pellucida, and two haploid pronuclei, 20% corresponds to the mutation in single DNA copy. A summary of all RFLP analyses from embryos co-injected with antibodies to Ku70/86 and ssDNA is presented in Table 1 .
Since NHEJ is the predominant mechanism of dsDNA break repair in mammalian cells, 24 we co-injected the ssDNA construct with nuclear extract prepared from human 293 cells as described earlier 25 to stimulate the NHEJ repair machinery. RFLP analysis of genomic DNA from this experiment shows no increase in alteration frequency, compared to injection of the ssDNA construct alone (data not shown).
DNA-binding protein Rad51, together with Rad54, are key factors in HR, and their importance in targeted mutagenesis has been suggested, 26 and demonstrated for episomal targets in yeast. 21 We used recombinant human Rad51 or Rad51KR protein, which has single amino-acid substitution (K133R), resulting in stronger DNA-binding activity, 26 alone, or in combination with Rad54, to stimulate targeted mutagenesis by co-injection with the ssDNA construct. From the results of RFLP analyses shown in Table 1 , it is evident that co-injection of HR factors with ssDNA does increase targeting efficiency. This paper describes the first successful case of targeted gene alteration in one-cell mouse embryos, the most ideal model system for genetic alteration of a whole organism. The novelty and significance of this work lie in the experimental demonstration that it is possible, with addition of exogenous proteins, to increase the frequency of targeted gene modification to a level where it may become practical to use in generating animal models. Our data further support involvement of the HR dsDNA break repair pathway proteins in targeted mutagenesis mediated by ssDNA, and conversely suggest that factors of the competing NHEJ pathway have inhibitory effects on this type of gene alteration system.
Efforts to employ targeted mutagenesis in early stage mouse embryos were previously described. 1 Our data are completely consistent with that study, showing no successful targeting events when only chimeric RNA/ DNA is used as a mutagen. Moreover, we extend this Targeted mutagenesis in early mouse embryos V Morozov and EF Wawrousek observation to encompass a morpholino and ssDNA constructs, which, not unexpectedly, also showed no successful targeting events when injected alone, suggesting that the base mismatch repair system is not sufficient to effect a gene alteration. However, in this work, undetectable targeted gene alteration efficiency was improved by supplementation of the pronuclear milieu with protein factors that stimulate gene modification, or inhibit proteins in competing pathways. This methodology of directly providing mouse embryo pronuclei with protein factors has not been previously described, and we believe that this technique has enormous potential for future use. In addition to providing the needed factors immediately without transcription/translation, it does not allow the possibility of DNA vectors encoding these factors to incorporate into the genome and wreak havoc subsequently. Overexpression of Rad51 and Rad54 was reported to stimulate gene modification in yeast cells, 21 which suggests involvement of the HR pathway. Consistent with that, we show a strong increase of alteration efficiency when mouse embryos were supplied with Rad51 recombinant protein. Co-injection of Rad54 with Rad51 further increases this effect. Remarkably, suppression of an alternative pathway of NHEJ, by co-injection of ssDNA with antibodies to the Ku heterodimer, also increases mutation efficiency. Consistent with this, co-injection of ssDNA or chimeric RNA/DNA constructs with mammalian cell nuclear extract, or whole DNA-PK complex, or antibodies to Rad51 protein (data not shown) did not produce a detectable alteration frequency. Collectively, our data suggest involvement of, and stimulation by, Rad51/54 proteins from the HR repair pathway in this type of targeted mutagenesis, as well as inhibition by Ku70/86 proteins from the competing NHEJ pathway.
Based on nested PCR and RFLP techniques, we have developed and applied a novel and highly sensitive method for detecting induced point mutations. From quantitative analysis of band intensities in RFLP analyses (Figure 2c ), we were able to effect and detect a mutation in a single DNA copy. Further study of conditions that could increase the efficiency of targeted mutagenesis even more is essential.
The number of embryos used in each experiment was limited in practical terms to the embryos that could be handled by one person for one day of routine transgenic mouse production (usually 100-200 embryos). In some cases, when efficiency of alteration was less than 1%, we did not have statistically significant data to calculate the actual alteration efficiency. In these cases, efficiencies reported as 0 could in reality be any positive number less than 1 Â 10
À2
. In this study we did not address aspects of embryo survival and development after co-injecting mutagenic constructs with potentiating proteins. Pharmacological effects, including dose dependency, need to be studied for each co-injected factor to make this method practical and useful in gene therapy and genetic engineering of animal models. Dose-dependent developmental arrest of sea urchin embryos was reported after injection of mouse monoclonal antibodies to the Ku protein. 27 No cases of developmental arrest were observed in our study when rabbit polyclonal anti-Ku antibodies were co-injected into mouse embryos. Survival and development rate were similar to experiments when only the DNA construct was injected. We are currently developing transgenic mouse lines in which correction of a nonsense mutation in a fluorescent protein will give an instant readout, and many embryos can be screened simultaneously. Such a transgenic mouse model could be an invaluable tool for further in-depth study of oligonucleotide and oligonucleotide-like constructs and conditions that could elevate alteration frequency in mouse embryos and increase embryo survival after injection. Efficiency significance was calculated in each case by one-tailed Fisher's exact test. e Alteration efficiency determined as 0%, however, if efficiency was less than 1% the number of surviving embryos was not statistically significant to calculate the actual alteration efficiency. f ND, not determined. The number of surviving embryos was not statistically significant to calculate the actual alteration efficiency.
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